Mps Iiia clinical trials

Explore recruiting mps iiia clinical trials.

Recruiting mps iiia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mps Iiia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Long-term Follow-up Study of Patients with MPS IIIA from Gene Therapy Clinical Trials Involving the Administration of ABO-102 (scAAV9.U1a.hSGSH)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I/II study of weekly infusions of JR-441 in patients with mucopolysaccharidosis type IIIA

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Mps Iiia trials by city

Mps Iiia in Toronto Mps Iiia in Vancouver Mps Iiia in Montreal Mps Iiia in Calgary Mps Iiia in Edmonton Mps Iiia in Ottawa Mps Iiia in Winnipeg Mps Iiia in Quebec City Mps Iiia in Hamilton Mps Iiia in Kitchener Mps Iiia in London Mps Iiia in Halifax Mps Iiia in New York Mps Iiia in Los Angeles Mps Iiia in Chicago Mps Iiia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease